RxDoctor Payments Data

VITROS XT 3400 Chemistry System: payments to doctors

Payments that named VITROS XT 3400 Chemistry System as the associated device or medical supply, reported under the Sunshine Act for program years 20192025.

Was your doctor paid by Ortho-clinical Diagnostics, Inc.?

Ortho-clinical Diagnostics, Inc. reported the most payments naming VITROS XT 3400 Chemistry System. Search your clinician to see whether they are among them — and what else they were paid for.

Finding a payment is not a finding of wrongdoing — most reported payments are a meal during a presentation. What matters is the kind, the size, and how it compares with their peers, which is what the profile shows.

Total reported
$33K
Providers
0
Transactions
6
Average per transaction
$5,549

The per-transaction average — $5,549 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. No payment naming this product was reported to an individual clinician. The Sunshine Act also covers payments to teaching hospitals as institutions — research funding, grants and device loans — and for this product that is all of it.

Companies reporting these payments

CompanyTotal reportedShare
Ortho-clinical Diagnostics, Inc.$33,296100.0%

Other products from Ortho-clinical Diagnostics, Inc.

The company that reported the most payments naming VITROS XT 3400 Chemistry System also reports against these.

← All drugs & devices